First person profile: Robert L. Ferris, MD, PhD

This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. This issue features Dr Robert L. Ferris, who was one of the first adopters of developing neoadjuvant trials to understand the immune mechanisms of action of immunotherapy agents. In addition, a common diagnostic approach to identify endometrial cancer may not be reliable for Black women, and women with more severe forms of endometriosis have a nearly 10‐fold higher risk of ovarian cancer.